Seraph Biosciences Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $7.12M

  • Investors
  • 1

Seraph Biosciences General Information

Description

Developer of real-time pathogen detection systems designed to treat infections at the point of care. The company represents a paradigm shift away from current methods for screening and identification of dangerous bacterial, viral, and fungal pathogens, enabling healthcare providers to effectively eliminate the need for time-consuming and costly laboratory-based methods of specimen collection, processing, and pathogen identification.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1001 Woodward Avenue
  • Suite 500
  • Detroit, MI 48226
  • United States
+1 (313)
Primary Industry
Monitoring Equipment
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Corporate Office
  • 1001 Woodward Avenue
  • Suite 500
  • Detroit, MI 48226
  • United States
+1 (313)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Seraph Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 16-Aug-2021 $7.12M Completed Generating Revenue
3. Later Stage VC (Series B) 03-Jan-2019 Completed Startup
2. Later Stage VC (Series A) 28-May-2017 $5M $5.25M Completed Startup
1. Angel (individual) 21-Oct-2015 $250K $250K Completed Startup
To view Seraph Biosciences’s complete valuation and funding history, request access »

Seraph Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A
To view Seraph Biosciences’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Seraph Biosciences Patents

Seraph Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4275035-A1 Raman-based systems and methods for material identification Inactive 05-Jan-2021
US-20240060899-A1 Raman-based systems and methods for material identification Pending 05-Jan-2021
ES-2877351-T3 Micro-raman-based portable detection instrument and detection method Active 07-Aug-2013
EP-3922965-A2 Hand-held micro-raman based detection instrument and method of detection Inactive 07-Aug-2013
US-11236379-B2 Raman based detection instrument and method of detection Active 07-Aug-2013 G01J3/18
To view Seraph Biosciences’s complete patent history, request access »

Seraph Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Seraph Biosciences Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Invest Detroit Ventures Corporate Venture Capital Minority
To view Seraph Biosciences’s complete investors history, request access »

Seraph Biosciences FAQs

  • When was Seraph Biosciences founded?

    Seraph Biosciences was founded in 2011.

  • Where is Seraph Biosciences headquartered?

    Seraph Biosciences is headquartered in Detroit, MI.

  • What is the size of Seraph Biosciences?

    Seraph Biosciences has 7 total employees.

  • What industry is Seraph Biosciences in?

    Seraph Biosciences’s primary industry is Monitoring Equipment.

  • Is Seraph Biosciences a private or public company?

    Seraph Biosciences is a Private company.

  • What is Seraph Biosciences’s current revenue?

    The current revenue for Seraph Biosciences is .

  • How much funding has Seraph Biosciences raised over time?

    Seraph Biosciences has raised $16.6M.

  • Who are Seraph Biosciences’s investors?

    Invest Detroit Ventures has invested in Seraph Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »